Mice deficient in the megakaryoblastic leukaemia 1 (Mkl1) gene experience less severe dextran sulphate sodium (DSS)-induced colitis, implying that Mkl1 plays a pathological role in inflammatory bowel disease (IBD). However, the contribution of Mkl1 to the development of colitis remains to be elucidated. The expression of Mkl1 is higher in the colonic lamina propria macrophages (LPMac) of DSS-treated mice than in those of control mice. Therefore, we established a transgenic mouse line that overexpresses human MKL1 (MKL1-Tg) specifically in cells of the monocyte/macrophage lineage, in order to investigate the potential role of macrophage MKL1 in the pathogenesis of colitis. MKL1-Tg mice displayed spontaneous colon shortening and rectal prolapse. Flow cytometric and quantitative RT-PCR analyses revealed that, in MKL1-Tg mice compared to littermate controls, the population of LPMac was decreased and had an altered inflammatory phenotype indicative of impaired anti-inflammatory properties, whereas bone marrow-derived macrophages from MKL1-Tg mice skewed towards M1 polarisation. In addition, MKL1-Tg mice had higher susceptibility to DSS-induced colitis than their littermate controls. These observations indicated that MKL1 crucially contributes to the development of colitis via the regulation of the function of macrophages, suggesting that it may be a potential therapeutic target for the prevention of IBD.
Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is characterised by chronic, progressive inflammation of the gastrointestinal tract. IBD arises from immune dysfunction, in which aberrant immune responses evoke excessive inflammation 1, 2 . It is widely accepted that both genetic and environmental factors are involved in the pathogenesis of IBD 1, 3 ; however, the precise aetiology is still not well understood. Megakaryoblastic leukaemia 1 (MKL1), also called myocardin-related transcription factor A, is an actin-binding protein that shuttles between the cytoplasm and nucleus in response to Rho-Rock signalling 4 . In the nucleus, MKL1 mediates various cellular functions as a co-activator of serum response factor. For example, MKL1 plays a key role in the regulation of the proliferation and migration of vascular smooth muscle cells 5 . The functions of MKL1 in leukocytes have been intensively investigated. The loss of MKL1 in neutrophils results in the disruption of actin filaments and impaired phagocytosis, and a patient with homozygous nonsense mutations in MKL1 failed to efficiently clear bacteria 6 . In macrophages, MKL1 mediates the upregulation of pro-inflammatory cytokines in response to inflammatory stimuli 7 . Interestingly, murine experimental colitis is less severe in Mkl1-knockout mice 7 , suggesting the involvement of Mkl1 in IBD. Given that the immune system plays a central role in IBD, it is likely that MKL1 in leukocytes contributes to the development of colitis.
Macrophages constitute the most abundant population in the intestinal lamina propria. Through frequent interactions with the enteric microflora and crosstalk with the adaptive immune system, lamina propria macrophages (LPMac) govern the immune network, which is indispensable for gut defence and homeostasis 8 . Recent studies have indicated that LPMac derived from Ly6C + blood monocytes are highly 'educated'; despite being phagocytic, they are unresponsive to inflammatory stimuli and generally display anti-inflammatory properties 8, 9 . Collapses of gut homeostasis are often associated with alternations in the inflammatory phenotypes of LPMac 10, 11 , a hallmark of IBD.
In this study, we investigated the involvement of MKL1 in IBD. We found that the expression of Mkl1 was significantly elevated in LPMac, but not in whole colon tissue, in the setting of murine experimental colitis, compared to that in the steady state, suggesting an important role for MKL1 in macrophages in the development of IBD. We established a line of transgenic mice, which overexpress human MKL1 specifically in monocyte/ macrophage lineage cells (MKL1-Tg). We found that LPMac from MKL1-Tg mice had a perturbed inflammatory phenotype, and that dextran sulphate sodium (DSS)-induced colitis in MKL1-Tg mice was fulminant compared to that in littermate controls. In addition, we found that MKL1 overexpression was associated with skewed macrophage polarisation, which may underlie the molecular pathogenesis of IBD in MKL1-Tg mice.
Results
Elevated expression of Mkl1 in colonic LPMac in experimental colitis. We analysed the phenotypes of colonic LPMac by flow cytometry, using antibodies against CD45, CD11b, CD11c, CD64, Ly6C, and MHC-II 10, 11 . We observed that mice that received 3% DSS had a decreased proportion of LPMac accompanied by a significant increase in the proportion of lamina propria monocytes (LPMo) (Fig. 1A and Supplementary  Fig. S1 ). We next investigated the expression of Mkl1 in colonic tissues. In the steady state, isolated LPMo and LPMac showed comparable expression of Mkl1 (Fig. 1B) . However, LPMac, but not LPMo, had increased expression of Mkl1 in DSS-treated mice (Fig. 1B) . In addition, the expression of Mkl1 was unchanged in the colons of control and DSS-treated mice ( Supplementary Fig. S2 ). The upregulation of Mkl1 in LPMac was associated with decreased expression of Pparg (Supplementary Fig. S3 ). These observations suggested a potential role of macrophage Mkl1 in the pathogenesis of experimental colitis.
Establishment of MKL1-Tg mice. We established a transgenic mouse line that overexpresses human MKL1 specifically in monocytes/macrophages, driven by the human CD68 promoter element ( Supplementary  Fig. S4A and B). Compared with bone marrow monocytes, bone marrow-derived macrophages (BMDMs) from MKL1-Tg mice expressed higher levels of the transgene, MKL1 (Supplementary Fig. S4C ). We found that MKL1-Tg mice had lower body weights than their non-Tg littermates, which reached statistical significance approximately 8 months after birth ( Fig. 2A) . At approximately 4 months of age, MKL1-Tg mice showed spontaneous shortening of the colon (Fig. 2B ) and occasionally developed rectal prolapse (Fig. 2C) . Histological analysis revealed scattered cryptitis in the colonic epithelial layer of MKL1-Tg mice (Fig. 2D ). In addition, we observed infiltration of CD68 + cells into the colonic submucosal layer of MKL1-Tg mice (Fig. 2E ).
LPMac from MKL1-Tg mice had aberrant inflammatory phenotypes. Flow cytometric analysis showed that MKL1-Tg mice had more LPMo and fewer LPMac than control littermates ( Fig. 3A and Supplementary Fig. S5 ). To further investigate the perturbation of LPMac in MKL1-Tg mice, we isolated mRNA from LPMac and performed quantitative RT-PCR. We found that the expression of the tissue-resident macrophages markers Mrc1 and Cd163, and the receptors for the anti-inflammatory cytokines IL-10 and TGF-β, were lower in MKL1-Tg mice than in control littermates (Fig. 3B ). In addition, the expression of Pparg was significantly decreased in LPMac from MKL1-Tg mice ( Supplementary Fig. S6 ). Furthermore, cultured colonic lamina propria lymphocytes (LPLs) from MKL1-Tg mice produced more IFN-γ, IL-4, and IL-17 than those from non-Tg littermates (Fig. 3C ).
MKL1 orchestrated macrophage polarisation. Treatment with IFN-γ+ lipopolysaccharide (LPS) or
IL-4 in vitro polarises macrophages into classically activated (M1) or alternatively activated (M2) types, respectively. It is known that the transcriptional activity of MKL1 is regulated by its nuclear localisation, which depends on actin dynamics 4 . We observed that, in BMDMs, expression of ectopic MKL1 was markedly increased in Supplementary Fig. S7A ); this was associated with increased formation of cytoplasmic filamentous actin (F-actin) ( Supplementary Fig. S7B ), and led to downregulation of Pparg (Supplementary Fig. 7C ). Given that PPARγ regulates the polarisation of M2 macrophages 12 , we hypothesised that MKL1 overexpression would affect macrophage polarisation. Using flow cytometric analysis, we demonstrated that the expression of the M2 marker CD206 was suppressed both in vehicle-treated and IL-4-treated BMDMs from MKL1-Tg mice, compared to its expression in non-Tg controls ( Fig. 4A and Supplementary Fig. S8 ). Quantitative RT-PCR analysis showed impaired expression of the M2 marker genes Mrc1, Arg1, Chi3l3, and Retnla, in M2-polarised BMDMs from MKL1-Tg mice (Fig. 4B) . On the other hand, upon LPS stimulation, we detected significantly higher NF-κB p65 transcriptional activity in nuclear extracts of BMDMs from MKL1-Tg mice than in those from control mice ( Supplementary Fig. 7D ). Furthermore, expression of MKL1 promoted M1 polarisation, as indicated by increased expression of the pro-inflammatory genes Nos2, Il12b, Tnfa, and Il6 in MKL1-Tg mice (Fig. 4C) .
DSS-induced colitis is fulminant in MKL1-Tg mice.
As MKL1-Tg mice did not show spontaneous inflammation in the colonic mucosa until 8 weeks of age ( Supplementary Fig. S9 ), we examined their susceptibility to DSS-induced colitis at this age. Compared to control littermates, MKL1-Tg mice showed more prominent weight loss (Fig. 5A) and shortening of the colon (Fig. 5B) after administration of 3% DSS for 7 days. In addition, histopathological analyses indicated that lesions of immune infiltration and ulceration extended from the proximal to the distal region of the colon in MKL1-Tg mice, whereas control littermates showed similar, but relatively mild lesions, mainly in the distal colon (Fig. 5C ). Detailed histological assessment revealed that MKL1-Tg mice experienced more damaging colitis, especially of the proximal colon, as evidenced by the massive infiltration and penetration of inflammatory cells into the colonic tissues, including the lamina propria, submucosa, and muscle layers, and the destruction of the epithelial structure, accompanied by ulceration (Fig. 5D) . Notably, the LPMac compartment was further decreased in MKL1-Tg mice upon treatment with 3% DSS (Fig. 5E and Supplementary  Fig. S10 ).
In order to evaluate the histopathological features of the recovery, rather than the acute, phase of DSS-induced colitis, we induced colitis by a modified protocol. We administered 3% DSS for 5 days, followed by regular water for another 3 days (Supplementary Fig. S11A ). In the colitis recovery phase, MKL1-Tg mice still experienced more prominent colon shortening (Supplementary Fig. S11B ). Immunohistochemical analysis revealed prominent B cell infiltration and/or follicle formation in the colonic mucosa of MKL1-Tg mice, compared to that in control littermates, during the recovery phase (Supplementary Fig. S11C ). 
Green cells represent CD68
+ cells (arrowhead) infiltrating the colonic submucosal layer of MKL1-Tg mice.
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Discussion
IBD is globally focused because of the difficulty in understanding its complex aetiology. Murine DSS-induced colitis is a classical model for studying the pathogenesis of IBD 13 , and Mkl1-knockout mice are known to develop DSS-induced colitis of mitigated severity 7 . We observed elevated expression of Mkl1 in LPMac, but not in LPMo or the colon tissue, in DSS-treated mice. Given that MKL1 is involved in the regulation of macrophage activation 7 , we hypothesised that MKL1 in LPMac could modulate intestinal inflammation and, hence, contribute to the development of IBD.
CD68, or macrosialin in the mouse, is one of the canonical molecular markers of macrophages. Expression of CD68 increases substantially during the differentiation of monocytes into macrophages 14 . In order to investigate the role of MKL1 in LPMac in vivo, we selected the CD68 promoter element, which was reported to effectively drive transgene expression in macrophages, but not in dendritic cells, lymphocytes, or granulocytes, in the colon 15 , to generate an MKL1-Tg line. The human MKL1 transgene was successfully overexpressed in macrophages from MKL1-Tg mice. The transgene was also expressed in monocytes. However, its expression was much higher in BMDMs, indicating that the CD68 promoter was largely activated during differentiation into macrophages. We observed that MKL1-Tg mice had a decreased proportion of colonic LPMac and a reciprocally increased LPMo population, compared to non-Tg controls. Perturbation of LPMac phenotypes has been reported to affect the function of effector T and/or regulatory T cells in murine colitis models 11, 16 , and we detected increased production of IFN-γ, IL-4, and IL-17 by LPLs from MKL1-Tg mice compared to those from controls, indicating enhanced effector T cell responses.
Several molecules play key roles in maintaining the tolerogenic phenotype of LPMac. For example, IL-10 and TGF-β are major regulatory cytokines that shape gut homeostasis [17] [18] [19] [20] , and expression of their receptors, Il10ra, Il10rb, and Tgfbr2, on macrophages is essential for anti-inflammatory signalling 15, 16, 21 . The alterations to LPMac phenotypes found in MKL1-Tg mice were likely due to a loss of their anti-inflammatory properties; LPMac from MKL1-Tg mice had lower expression of Il10ra and Tgfbr2 than those from controls.
Although the evidence suggested that MKL1-Tg mice would be colitogenic, MKL1-Tg mice did not show overt symptoms of colitis, other than rectal prolapse. Nevertheless, cryptitis and infiltration of CD68 + cells into the submucosal layer indicated a pro-inflammatory environment in the MKL1-Tg mice. These observations indicate that MKL1-Tg mice are predisposed to develop colitis. Indeed, when MKL1-Tg mice were subjected to a DSS-induced colitis model, they showed higher susceptibility than non-Tg controls. Of note, the proximal B cell infiltration or follicle formation in the colonic mucosa is one of the particular histological features of the DSS-induced colitis model 22 ; although it could also reflect a reaction against epithelial irritation or local infection in the colon caused by DSS treatment 23 . DSS-induced migration of B cells into the mucosa mainly occurs relatively late after treatment 24 . To avoid excessive ablation and disruption of the mucosal layer by continuous DSS treatment, we examined the histopathology of the colon during the recovery phase of DSS-treated mice 23, 24 , and observed remarkable B cell infiltration and follicle formation in the colons of MKL1-Tg mice, suggesting that MKL1-Tg mice underwent fulminant colonic inflammation.
Consistent with a previous report, we found that MKL1 overexpression increased its nuclear localisation and promoted the formation of F-actin, both of which have been reported as prerequisite molecular events to suppress the expression of Pparg
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. The nuclear receptor PPARγ is mainly expressed in adipose tissue and the colon. PPARγ in macrophages plays a protective role against the development of inflammatory diseases, such as atherosclerosis, obesity, and colitis 12, 26, 27 . PPARγ is also a master regulator of macrophage M2 polarisation 12 . In this regard, we found that MKL1 overexpression blunted M2 macrophage polarisation. In addition, we found that, even without IL-4 treatment, BMDMs from MKL1-Tg mice had compromised CD206 expression, which is consistent with previous reports that M-CSF primes M2-prone macrophages 28, 29 . One of the most important functions of MKL1 is to regulate the expression of pro-inflammatory cytokines, which it accomplishes by interacting with NF-κB p65 7 . We found that, under pro-inflammatory conditions, MKL1 overexpression significantly enhanced the transcriptional activity of NF-κB p65 and boosted M1 macrophage polarisation. These observations indicate that MKL1 orchestrates macrophage M1/M2 polarisation through interactions with other transcription factors; our results support the hypothesis that M2 macrophages protect against DSS-induced and other forms of murine experimental colitis 16, 30 .
In conclusion, our study revealed the impact of MKL1 in macrophages on the development of colitis. In particular, we found that MKL1 regulates the inflammatory properties of macrophages. Our observations suggest that MKL1 may be a potential therapeutic target for the treatment of IBD. 
Methods
Animal experiments. C57BL/6 J mice were purchased from CLEA Japan. For the establishment of MKL1-Tg mice, a complementary DNA (cDNA) fragment encoding human MKL1 was tagged with a FLAG cDNA sequence at the 5′ end, then cloned downstream of a modified human CD68 promoter element (a kind gift from Peter. J. Murray, St. Jude Children's Research Hospital). The designed expression cassette, containing the driving promoter, IVS1, the target gene, and the BGH polyA tail, was excised using SalI and DraIII, then injected into the male pronucleus of a C57BL/6 J egg, which was implanted into a pseudo-pregnant female recipient mouse. The transgenic offspring were genotyped by PCR. For the DSS-induced colitis model, mice (8-12 weeks) received 3% DSS (160110, M.W. = 36,000-50,000, MP Biomedicals), dissolved in drinking water, for specified periods, depending on the assay. All animal care and experimental procedures were in accordance with the guidelines for the Care and Use of Laboratory Animals published by the National Research Council (The National Academy Presses, 8th edition, 2011), and were subjected to prior approval by the local animal protection authority of the Tokyo Medical and Dental University (TMDU).
Histological and immunohistochemical analyses. We euthanised mice and excised theirs colons,
which were cut open longitudinally and rinsed in 1 × PBS to remove faeces, then fixed in a Swiss roll shape in 10% Formalin Neutral Buffer Solution (Wako). Paraffin-embedded sections were stained with haematoxylin and eosin (H&E) for histological assessment. The disease severity was evaluated according to a previously described scoring system 31 . The total score was given by the sum of the scores for the proximal, middle, and distal regions of the colon. For immunohistochemical analysis, fresh colon tissues were embedded in OCT compound (Sakura Finetek). Frozen sections were fixed in 4% paraformaldehyde (PFA), blocked in Blocking One (Nacalai Tesque), + CD11b + CD11c low to mid CD64 + cells. We calculated the proportions of LPMac. Experiments were repeated 3 times. Data are shown as mean ± SD. *P < 0.05.
